200 related articles for article (PubMed ID: 32416725)
21. Antimicrobial activity and biofilm inhibition of riparins I, II and III and ultrastructural changes in multidrug-resistant bacteria of medical importance.
Oliveira-Júnior JB; da Silva EM; Veras DL; Ribeiro KRC; de Freitas CF; de Lima FCG; Gutierrez SJC; Camara CA; Barbosa-Filho JM; Alves LC; Brayner FA
Microb Pathog; 2020 Dec; 149():104529. PubMed ID: 33010367
[TBL] [Abstract][Full Text] [Related]
22. Riparin A, a compound from Aniba riparia, attenuate the inflammatory response by modulation of neutrophil migration.
Silva RO; Damasceno SR; Silva IS; Silva VG; Brito CF; Teixeira AÉ; Nunes GB; Camara CA; Filho JM; Gutierrez SJ; Ribeiro RA; Souza MH; Barbosa AL; Freitas RM; Medeiros JV
Chem Biol Interact; 2015 Mar; 229():55-63. PubMed ID: 25656915
[TBL] [Abstract][Full Text] [Related]
23. Anxiolytic, antidepressant, and antistress activities of the aqueous extract of
Upadhyay G; Khoshla S; Kosuru R; Singh S
Indian J Pharmacol; 2016; 48(5):555-561. PubMed ID: 27721543
[TBL] [Abstract][Full Text] [Related]
24. In vitro inhibition and eradication of multidrug-resistant Acinetobacter baumannii biofilms by riparin III and colistin combination.
Oliveira Júnior JB; Rocha da Mota DA; de Lima FCS; Higino TMM; Chavez Gutierrez SJ; Camara CA; Barbosa Filho JM; Alves LC; Brayner FA
Microb Pathog; 2023 Sep; 182():106233. PubMed ID: 37422173
[TBL] [Abstract][Full Text] [Related]
25. The effects of moclobemide on the yohimbine-induced anxiogenic action in the elevated plus-maze.
Eroğlu L; Güven O
Pharmacol Res; 1998 Feb; 37(2):137-43. PubMed ID: 9572069
[TBL] [Abstract][Full Text] [Related]
26. New evidence for refinement of anesthetic choice in procedures preceding the forced swimming test and the elevated plus-maze.
Herbst LS; Gaigher T; Siqueira AA; Joca SRL; Sampaio KN; Beijamini V
Behav Brain Res; 2019 Aug; 368():111897. PubMed ID: 30978407
[TBL] [Abstract][Full Text] [Related]
27. New insights about the antidepressant-like effects of riparin A in a chronic murine model of depression.
Prinholato da Silva C; Oliveira DD; Benincasa BI; Barbar B; Perri RGB; Fachin AL; Falconi-Sobrinho LL; Beleboni RO
Behav Pharmacol; 2024 Jun; ():. PubMed ID: 38869060
[TBL] [Abstract][Full Text] [Related]
28. Anxiolytic-like effects of nociceptin/orphanin FQ in the elevated plus maze and in the conditioned defensive burying test in rats.
Vitale G; Arletti R; Ruggieri V; Cifani C; Massi M
Peptides; 2006 Sep; 27(9):2193-200. PubMed ID: 16730097
[TBL] [Abstract][Full Text] [Related]
29. GABAA/benzodiazepine receptor complex mediates the anxiolytic-like effect of Montanoa tomentosa.
Sollozo-Dupont I; Estrada-Camarena E; Carro-Juárez M; López-Rubalcava C
J Ethnopharmacol; 2015 Mar; 162():278-86. PubMed ID: 25582489
[TBL] [Abstract][Full Text] [Related]
30. Spectral and computational features of the binding between riparins and human serum albumin.
Camargo CR; Caruso ÍP; Gutierrez SJC; Fossey MA; Filho JMB; Cornélio ML
Spectrochim Acta A Mol Biomol Spectrosc; 2018 Feb; 190():81-88. PubMed ID: 28915468
[TBL] [Abstract][Full Text] [Related]
31. Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines.
Sugiyama A; Saitoh A; Iwai T; Takahashi K; Yamada M; Sasaki-Hamada S; Oka J; Inagaki M; Yamada M
Neuropharmacology; 2012 Jun; 62(8):2489-98. PubMed ID: 22377384
[TBL] [Abstract][Full Text] [Related]
32. Different pathways mediated by CCK1 and CCK2 receptors: effect of intraperitonal mrna antisense oligodeoxynucleotides to cholecystokinin on anxiety-like and learning behaviors in rats.
Cohen H; Kaplan Z; Matar MA; Buriakovsky I; Bourin M; Kotler M
Depress Anxiety; 2004; 20(3):139-52. PubMed ID: 15487014
[TBL] [Abstract][Full Text] [Related]
33. The gerbil elevated plus-maze II: anxiolytic-like effects of selective neurokinin NK1 receptor antagonists.
Varty GB; Cohen-Williams ME; Morgan CA; Pylak U; Duffy RA; Lachowicz JE; Carey GJ; Coffin VL
Neuropsychopharmacology; 2002 Sep; 27(3):371-9. PubMed ID: 12225694
[TBL] [Abstract][Full Text] [Related]
34. Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions.
Micale V; Tamburella A; Leggio GM; Mazzola C; Li Volsi V; Drago F
Pharmacol Biochem Behav; 2008 Sep; 90(3):463-9. PubMed ID: 18495229
[TBL] [Abstract][Full Text] [Related]
35. Anxiolytic- and antidepressant-like properties of ketamine in behavioral and neurophysiological animal models.
Engin E; Treit D; Dickson CT
Neuroscience; 2009 Jun; 161(2):359-69. PubMed ID: 19321151
[TBL] [Abstract][Full Text] [Related]
36. The gerbil elevated plus-maze I: behavioral characterization and pharmacological validation.
Varty GB; Morgan CA; Cohen-Williams ME; Coffin VL; Carey GJ
Neuropsychopharmacology; 2002 Sep; 27(3):357-70. PubMed ID: 12225693
[TBL] [Abstract][Full Text] [Related]
37. Anxiolytic and antidepressant effect of zinc on rats and its impact on general behavioural parameters.
Samardzić J; Savić K; Stefanović N; Matunović R; Baltezarević D; Obradović M; Jancić J; Oprić D; Obradović D
Vojnosanit Pregl; 2013 Apr; 70(4):391-5. PubMed ID: 23700944
[TBL] [Abstract][Full Text] [Related]
38. Behavioral tests and oxidative stress evaluation in mitochondria isolated from the brain and liver of mice treated with riparin A.
Nunes GB; Costa LM; Gutierrez SJ; Satyal P; de Freitas RM
Life Sci; 2015 Jan; 121():57-64. PubMed ID: 25476826
[TBL] [Abstract][Full Text] [Related]
39. Anxiolytic effect of clonazepam in female rats: grooming microstructure and elevated plus maze tests.
Nin MS; Couto-Pereira NS; Souza MF; Azeredo LA; Ferri MK; Dalprá WL; Gomez R; Barros HM
Eur J Pharmacol; 2012 Jun; 684(1-3):95-101. PubMed ID: 22487059
[TBL] [Abstract][Full Text] [Related]
40. Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Griebel G; Simiand J; Serradeil-Le Gal C; Wagnon J; Pascal M; Scatton B; Maffrand JP; Soubrie P
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6370-5. PubMed ID: 11959912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
